📢Thrilled to announce that the sixth site for the BCIS-4 trial is now open at Nottingham University Hospitals NHS Trust🎉! Huge thanks to the team at Nottingham City Hospital for their rapid action in advancing this vital research. On to the next step!🚀 Andrew Vanezis #BCIS4

Happy Friday everyone 🥳 Here is this weeks RECAP! 1) EASY-AS has 3 randomised participants. 2) COLO-PREVENT Trial had 1 randomised participant. 3) @TRiCSIV_UK were busy with an Site initiation visit and also had 1 randomised participant. Amazing work everyone 😇

Congratulations to Hull for their 2nd randomisation of the month. This brings them to an overall total of 19 recruits making them the 2nd highest recruiter nationally! Leicester Clinical Trials Unit Hull University Teaching Hospitals NHS Trust Daniel Carradice Athanasios Saratzis

🎉 Huge congratulations to Royal Papworth Hospital NHS FT 💙 for randomising your 8th participant—Amazing work, team! 🙌 #TRICSIV hits an incredible milestone with 40 participants! 💪 Leicester Clinical Trials Unit gavin murphy Andrew Klein Unity Health Toronto

📢Exciting news! The seventh site for the BCIS-4 trial is now live at University Hospitals Birmingham NHS Foundation Trust! 🎉 A massive thank you to the QE Hospital team for their hard work in advancing this important research. On to the next milestone! 🚀🌟#BCIS4 sohail khan

Congratulations to both Dudley and St Thomas's yesterday for randomising to the EVOCC trial! This brings our total to 10 recruits for this month! Athanasios Saratzis The Dudley Group Guy's and St Thomas' Leicester Clinical Trials Unit

📢A nod to the Castle Hill site who have pulled a second randomisation out of the bag in January 🥳in what has been a slow month. With only two days left, will it be your site who narrows the gap to the 1000th participant? Leicester Clinical Trials Unit British Heart Foundation #ICVDV Centre for Cardiovascular Diseases AZ Sint-Jan Brugge AV

In this study of 428700 admissions with ACS, #women, black #ethnicity, #multimorbid & #frail patients were less likely to undergo revascularisation, & women had higher unadjusted 1-year mortality than men. Prof Julie Sanders Professor Vijay Kunadian gavin murphy academic.oup.com/ehjqcco/articl…

We propose that ACS outcomes attributed to women & people of South Asian ethnicity may be attributable to age, comorbidity & frailty at presentation …

Our updated European Society of Cardiology quality indicators for the management of acute coronary syndrome. academic.oup.com/ehjacc/article…

📢What a Monday it's shaping up to be. 3 rand's so far today, including a 4th, in 4 months by Wansbeck. Great work! 🥳We are now only T E N rand's away from 1000!! Leicester Clinical Trials Unit British Heart Foundation National Institute for Health and Care Research Clinical Research AU Heart Foundation NZ #ICVDV Innovation Research and Development @ Northumbria AZ Sint-Jan Brugge AV Centre for Cardiovascular Diseases

Congratulations North Tees and Hartlepool NHS Foundation Trust for randomising their 13th participant to the Main Trial!! Great work!! #coloprevent Science and Innovation at Cancer Research UK Karen Brown 𝗗𝗿 𝗔𝗷𝗮𝘆 𝗠 𝗩𝗲𝗿𝗺𝗮

We have now completed 10 Site initiation Visits and are half-way to our goal of 20. We will be opening our first sites soon. Follow us on here for more updates. #PerformTrial #LeicesterCTU

ROMA Women are excited to share that we have now exceeded 'GREEN' in the progression criteria of 84 recruited participants. The current recruitment is 88 participants 🎉 With 14 recruited for the year so far 🎊 Keep up the great work everyone! gavin murphy Weill Cornell Medicine

It is really humbling and I am honoured to have our work featured in the editorial of Prof Crea EHJ Editor-in-Chief European Society of Cardiology European Society of Cardiology Journals : New light shed on sex-related risk factors and frailty. doi.org/10.1093/eurhea…

Congratulations to Dudley who yesterday randomised the 2nd patient of the month! Athanasios Saratzis The Dudley Group Leicester Clinical Trials Unit

A massive welcome to Cardiff & Vale who are the latest site to join EVOCC!@a_saratzis Leicester Clinical Trials Unit

The findings in EASY-AS, the largest RCT in severe asymptomatic AS are expected to confirm if the strategy of early AVR may improve the outcome of these patients 👍❤️

Weekly recap from the work of the Leicester Clinical Trials unit: 1) PERFORM Trial completed their 11th SIV this week. 2) EASY-AS Randomised 4 participants this week 3) BCIS completed 1 SIV this week 4) COLO-PREVENT Trial randomised 1 participant in their sub-trial 🥳